Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Structure/function claims preclearance by FDA recommended by Berkeley professor.

This article was originally published in The Tan Sheet

Executive Summary

STRUCTURE/FUNCTION CLAIM PRECLEARANCE BY FDA RECOMMENDED by University of California at Berkley nutrition professor Doris Calloway, PhD, at the April 26 meeting of the Commission on Dietary Supplement Labels in San Francisco. "Structure and function claims on dietary supplements should be cleared by the FDA prior to use, and documentation supporting those claims should be readily available to the scientific community," Calloway asserted.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS085385

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel